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Background: The cell envelope of a bacterial pathogen can be damaged by harsh conditions in the environment
outside a host and by immune factors during infection. Cell envelope stress responses preserve the integrity of this
essential compartment and are often required for virulence. Bordetella species are important respiratory pathogens
that possess a large number of putative transcription factors. However, no cell envelope stress responses have been
described in these species. Among the putative Bordetella transcription factors are a number of genes belonging to
the extracytoplasmic function (ECF) group of alternative sigma factors, some of which are known to mediate cell
envelope stress responses in other bacteria. Here we investigate the role of one such gene, sigE, in stress survival
and pathogenesis of Bordetella bronchiseptica.
Results: We demonstrate that sigE encodes a functional sigma factor that mediates a cell envelope stress response.
Mutants of B. bronchiseptica strain RB50 lacking sigE are more sensitive to high temperature, ethanol, and
perturbation of the envelope by SDS-EDTA and certain β-lactam antibiotics. Using a series of immunocompromised
mice deficient in different components of the innate and adaptive immune responses, we show that SigE plays an
important role in evading the innate immune response during lethal infections of mice lacking B cells and T cells.
SigE is not required, however, for colonization of the respiratory tract of immunocompetent mice. The sigE mutant
is more efficiently phagocytosed and killed by peripheral blood polymorphonuclear leukocytes (PMNs) than RB50,
and exhibits decreased cytotoxicity toward macrophages. These altered interactions with phagocytes could
contribute to the defects observed during lethal infection.
Conclusions: Much of the work on transcriptional regulation during infection in B. bronchiseptica has focused on
the BvgAS two-component system. This study reveals that the SigE regulon also mediates a discrete subset of
functions associated with virulence. SigE is the first cell envelope stress-sensing system to be described in the
bordetellae. In addition to its role during lethal infection of mice deficient in adaptive immunity, our results indicate
that SigE is likely to be important for survival in the face of stresses encountered in the environment between
hosts.
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The cell envelope of bacterial pathogens is critical for
survival both in a host during infection and in the envir-
onment outside of the host. As the interface between the
bacterium and the outside milieu, the cell envelope acts
as a barrier protecting the cell against extracellular
hazards. Cell envelope structures are also intimately
involved in the formation of contacts with host tissues
during infection. To safeguard this important compart-
ment, gram-negative bacteria possess an array of stress
responses that sense conditions in the cell envelope and
alter gene expression to ensure its integrity [1,2]. In
many bacterial pathogens, cell envelope stress responses
play a multifaceted role. They provide protection against
damage caused by components of the immune system,
such as complement and antimicrobial peptides that
target the cell envelope [3-5]. They regulate the expres-
sion of chaperones required for proper assembly of cell
envelope-associated structures, including outer mem-
brane porins, pili, and fimbrae [3,6,7]. In addition, cell
envelope stress responses can sense the environment
around the bacterium and regulate the expression of
virulence factors in response to specific cues, ensuring
that these factors are expressed at the proper time and
location in the host [2,8]. Despite their importance, no
cell envelope stress responses have yet been identified or
implicated in pathogenesis in Bordetella species.
Bordetella bronchiseptica is a respiratory pathogen that
is closely related to Bordetella pertussis and Bordetella
parapertussis, the causative agents of whooping cough in
humans [9,10]. B. bronchiseptica causes a range of
diseases in various mammals that can be chronic,
difficult to completely eradicate, and of variable viru-
lence [11-13]. It is the etiological agent of atrophic rhin-
itis in swine, kennel cough in dogs, and snuffles in
rabbits [12,13]. Documented human infections, generally
traced to an animal source, have been observed in im-
munocompromised individuals, and can be serious, sys-
temic infections [11,14].
The B. bronchiseptica, B. pertussis and B. parapertussis
genomes encode a large number of putative transcrip-
tion factors relative to their overall genome size [15],
suggesting that these pathogens have the capacity to ex-
tensively regulate gene expression in response to envir-
onmental and physiological changes. Despite this
finding, only a few Bordetella transcription factors have
been studied in any detail [16-20]. Among the predicted
transcription factors is an ortholog of the cell envelope
stress response sigma factor, σE, of E. coli. In bacteria,
sigma factors are the subunits of bacterial RNA poly-
merases required for specific promoter recognition and
transcription initiation [21]. Alternative sigma factors,
like σE, are activated in response to specific stresses and
rapidly reprogram gene expression by replacing thehousekeeping sigma factor and directing RNA polymer-
ase to the genes in their regulons [21,22].
σE belongs to the RpoE-like group of extracytoplasmic
function (ECF) sigma factors that have been increasingly
implicated as key factors contributing to both bacterial
stress responses and virulence [23,24]. These sigma fac-
tors are widely distributed across bacterial phyla. Where
studied, they direct a diverse set of stress responses pri-
marily targeted to the cell envelope [2,8,24,25]. In E. coli
and Salmonella enterica serovar Typhimurium, σE con-
trols many genes whose products are required for the
proper expression of outer membrane porins and LPS
[26,27]. During infection, σE of S. Typhimurium is
required for survival and proliferation in epithelial and
macrophage cell lines, and in the presence of antimicro-
bial peptides [6,28,29]. In Pseudomonas aeruginosa, the
σE homologue, AlgU, controls the expression of the exo-
polysaccharide alginate and conversion to mucoidy.
AlgU is constitutively activated in many clinical isolates
from cystic fibrosis patients [30,31]. In addition, σE is
required for the viability of some bacterial species, but
not others. The gene encoding σE is essential in E. coli
and Yersinia enterocolitica, but is dispensable in the
closely related species S. Typhimurium [6,32,33]. These
observations suggest that the functions of σE orthologs
have been adapted to combat the challenges each organ-
ism faces in its particular environmental niche. By
exploring the role of σE in diverse bacterial species, we
can learn which aspects of this widespread regulatory
pathway are universally conserved and which have
diverged over the course of evolution.
Here we show that the B. bronchiseptica σE ortholog,
encoded by the gene sigE (BB3752), is an active sigma
factor that mediates a cell envelope stress response. This
is the first demonstration of an envelope stress-sensing
system in Bordetella species. Using a murine infection
model, we demonstrate that SigE plays an important role
during lethal infection in mice lacking adaptive immun-
ity, but not in respiratory tract colonization. This finding
has important implications for human disease, given the
observation that B. bronchiseptica can cause serious sys-
temic infections in immunocompromised humans
[11,14]. This study suggests that SigE is a critical factor
in this process, in addition to the BvgAS master viru-
lence regulatory system.
Results
sigE encodes an active sigma factor
The sigE gene of B. bronchiseptica shares a number of
conserved residues with other members of the RpoE-like
sigma factors, including those in the DNA-binding
regions (Figure 1A) [24]. To determine if sigE encodes
an active sigma factor, we asked whether it could direct
transcription from the σE-dependent rpoHP3 promoter
Figure 1 B. bronchiseptica SigE is a functional sigma factor. (A) Amino acid sequence alignment of RpoE- like sigma factors from Escherichia
coli (Ecoli), Vibrio cholerae (Vchol), Pseudomonas aeruginosa (Paer), Nitrosomonas europaea (Neur) and B. bronchiseptica (Bbron) using ClustalW2
(EMBL-EBI). Asterisks indicate identity, two dots indicate strong similarity, and one dot indicates weak similarity between amino acid residues.
Conserved sigma factor regions 2.1-2.4 and 4.1-4.2 [22] are indicated above the alignment. Regions 2.3, 2.4, and 4.2 are responsible for promoter
recognition [22]. (B) β-galactosidase activity from the E. coli rpoHP3-lacZ reporter increases when B. bronchiseptica sigE expression is induced from
plasmid pSEB006 in strain SEA5005 by the addition of IPTG. No increase is seen upon IPTG addition to the control strain, SEA008, containing the
empty vector. The observed difference in the amount of β-galactosidase activity between the two strains in the presence of IPTG is statistically
significant (P value <0.001) (C) In vitro transcription from a supercoiled plasmid template containing the E. coli σE-dependent rpoHP3 promoter
with E. coli core RNA polymerase (core), SigE alone, EσE, and ESigE (left panel). In vitro transcription from a linear template containing the
promoter region of B. bronchiseptica fam, with E. coli core RNAP alone (core), or ESigE (right panel). Arrows indicate transcripts from the rpoHP3
and fam promoters. Below, an alignment of the E. coli rpoHP3 and B. bronchiseptica fam promoter sequences and a sequence logo showing the
consensus promoter for RpoE-like (ECF02) sigma factors from Staron et al. [24].
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with a consensus promoter proposed for the RpoE-like
sigma factors that was determined from both experimen-
tal data and predicted promoter sequences (Figure 1C)[24,27]. The sigE gene from B. bronchiseptica strain RB50
was cloned into the pTrc99a expression plasmid and
transformed into a derivative of E. coli MG1655 that car-
ries an rpoHP3::lacZ reporter gene fusion integrated on
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induced, LacZ activity increased, indicating that SigE can
initiate transcription from this promoter (Figure 1B). Fur-
thermore, we found that the gene encoding σE, rpoE,
which is essential for viability in E. coli, could be deleted
when sigE was overexpressed (data not shown, see Mate-
rials and Methods).
To provide additional evidence that SigE is a func-
tional sigma factor, N-terminally His-tagged SigE was
purified and tested for its ability to initiate transcription
in vitro from the E. coli rpoHP3 promoter. Holoenzyme
formed with SigE and E. coli core RNA polymerase
(ESigE) was able to direct transcription and produced a
transcript of equivalent length to that generated by E.
coli EσE (Figure 1C). The region immediately upstream
of the B. bronchiseptica rpoH homologue, encoded by
the fam gene, contains a sequence that is similar to the
proposed σE-dependent consensus promoter, suggesting
that B. bronchiseptica rpoH is regulated by SigE. Indeed,
SigE was able to direct transcription from the putative
fam promoter region in vitro (Figure 1C). Taken to-
gether, these results demonstrate that SigE is a func-
tional sigma factor and can initiate transcription from
promoter sequences similar to those utilized by other
members of the RpoE-like sigma factor family.
sigE contributes to the B. bronchiseptica stress response
To investigate the role of SigE in B. bronchiseptica, an
in-frame deletion of the sigE gene was constructed in
RB50 (RB50ΔsigE) that removed 176 out of 200 codons
of the gene, leaving 22 and 2 codons at the 5´ and 3´
ends of the gene, respectively. The deletion was con-
firmed by PCR and Southern blotting methods (data not
shown). σE orthologs are essential in some bacteria, in-
cluding E. coli and Y. enterocolitica [33,35], yet are not
required for viability in many other species, such as S.
Typhimurium, P. aeruginosa, and Burkholderia pseudo-
mallei [6,36,37]. Deletions of B. bronchiseptica sigE were
readily obtained, suggesting that it falls in the latter
class, and is not essential for viability. Furthermore,
RB50ΔsigE grew at a rate similar to that of RB50 under
standard growth conditions (37°C in Stainer-Scholte
broth) (Figure 2A).
To investigate whether SigE mediates a cell envelope
stress response in B. bronchiseptica, we used disk diffu-
sion assays to compare the sensitivity of RB50 and
RB50ΔsigE to several chemicals that compromise cell
envelope integrity and a series of antibiotics that block
different steps in peptidoglycan synthesis. The sigE mu-
tant was more sensitive than the wild-type strain to the
detergent SDS in combination with EDTA (Figure 2B).
The sigE mutant was also more sensitive than wild-type
RB50 to the antibiotics mecillinam and ampicillin
(Figure 2B), whereas sensitivity to meropenem, aztreonam,and imipenem was not affected (data not shown). Unlike
σE orthologs in other bacteria, SigE was not required for
resistance to the cationic antimicrobial peptide polymyxin
B, which targets bacterial membranes, or to osmotic stress
(Figure 2B and data not shown) [6,36,38,39]. RB50ΔsigE
and RB50 were also equally sensitive to antibiotics that
inhibit cytoplasmic processes such as translation (chloram-
phenicol, erythromycin, kanamycin, tetracycline), transcrip-
tion (rifampicin), and cytoplasmic enzymes such as DNA
gyrase (nalidixic acid), and dihydrofolate reductase (tri-
methoprim) (data not shown). This lack of sensitivity to
multiple antibiotics suggests that the sigE mutation does
not lead to an overall increase in the permeability of the
outer membrane, which would allow more of the antibiotic
to enter the cell. These results show that SigE is important
for survival in response to specific types of damage to the
cell envelope, such as disruption of cellular membranes
caused by SDS/EDTA and interference with synthesis
of the peptidoglycan layer caused by ampicillin and
mecillinam.
We next asked if sigE is important for survival follow-
ing a shift to high temperature, which perturbs both the
cell envelope and cytoplasm. RB50 and RB50ΔsigE were
grown at 37°C to an OD600 of 0.4, then shifted to 50°C, a
lethal temperature for B. bronchiseptica. Cell viability,
assessed by CFU/ml, was measured after the shift to 50°
C. Survival of the RB50ΔsigE strain was lower than that
of RB50 (Figure 2C). In attempting to complement this
phenotype, we found that plasmid-encoded sigE did not
restore survival during heat shock (data not shown), al-
though it did complement other phenotypes, as
described below. Similar variability in complementation
of a σE mutant by a plasmid-encoded rpoE gene has
been seen in other bacteria [29,36,40,41]. Work from
Burkholderia cenocepacia showed that expressing σE
from a plasmid actually increased sensitivity to heat
stress [36]. In S. Typhimurium, an rpoE mutant was sen-
sitive to paraquat and did not survive in stationary phase
under anaerobic conditions. Expression of rpoE from a
plasmid partially complemented the former phenotype,
but not the latter [29]. Because the anti-sigma factor that
regulates σE activity was not included in any of these
instances, it is likely that proper regulation of SigE activ-
ity is required for optimal response to particular stresses,
not merely excess SigE activity, complicating comple-
mentation experiments.
Another aspect of the classical heat shock response is
thermotolerance. When bacteria are exposed to an ele-
vated but nonlethal temperature, heat shock responses are
induced, resulting in increased production of chaperones
and proteases that refold or degrade unfolded proteins
[42]. Consequently, the cells are preloaded with protective
factors and exhibit increased survival following a subse-
quent shift to a lethal temperature [42]. To investigate the
Figure 2 Role of SigE in response to environmental stresses. (A) RB50 (squares) and RB50△sigE (triangles) grow similarly at 37°C in Stainer-
Scholte broth. (B) RB50△sigE (white bars) is more sensitive than RB50 (grey bars) to treatment with 100 μg mecillinam, 10 μg ampicillin, or
750 μg SDS and 2.9 μg EDTA, but is similarly sensitive to treatment with 300 IU polymyxin B in disk diffusion assays. The average diameters of the
zones of inhibition± SE from at least three independent experiments are shown. The disk diameter was 6 mm. The observed differences between
the zones of inhibition for RB50 and the sigE mutant are statistically significant for mecillinam, ampicillin, and SDS-EDTA (* indicates a P-value
of < 0.05; ** indicates a P-value< 0.01). (C) RB50△sigE (triangles) is more sensitive than RB50 (squares) to heat shock (solid line, filled symbols)
caused by shifting cultures from 37°C to 50°C. RB50△sigE also exhibits reduced thermotolerance (dashed line, open symbols), surviving less well
than RB50 when adapted first to 40°C before a shift to 50°C. The mean percent survival±SE of fifteen independent experiments for each strain is
shown. (D) RB50△sigE containing the empty cloning vector pEV (open triangles) is more sensitive to treatment with 3% ethanol than RB50 pEV
(squares). Expression of plasmid-encoded SigE (RB50△sigE pSigE) restores growth in 3% ethanol (filled triangles) to near wild-type levels at the 6
and 12 hour time points and partially restores growth at the 24 hour time point. The mean OD600 ± SE of at least four independent experiments
is shown for each strain.
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were grown to an OD600 of 0.1 at 37°C, shifted to 40°C for
90 min, then shifted to 50°C. RB50 cultures incubated at
40°C before 50°C survived better at all time points than
those directly shifted from 37°C to 50°C. For example,
54% of the RB50 cells pre-adapted at 40°C survived two
hours after the shift to 50°C (Figure 2C) compared to 0.1%
survival for those shifted directly from 37°C to 50°C
(Figure 2C). RB50ΔsigE pre-adapted at 40°C also survived
better at 50°C than when directly shifted from 37°C to 50°C.
However, only 38% of the RB50ΔsigE cells survived after
one hour (compared to 76% of the wild-type RB50), and 5%
survived after two hours at 50°C (Figure 2C). These results
demonstrate that B. bronchiseptica exhibits a classical ther-
motolerance response and that SigE contributes to this
response.Both ethanol and heat shock lead to protein unfolding
and membrane perturbation and often elicit similar
stress responses [43]. To test the role of sigE in response
to ethanol stress, RB50 and RB50ΔsigE were subcultured
from mid-exponential-phase cultures into fresh Stainer-
Scholte broth with or without 3% ethanol. Both strains
grew similarly in medium without ethanol, as noted
above. RB50 grew significantly slower in medium con-
taining 3% ethanol than in medium without ethanol
(compare the growth curve for RB50 in Figure 2D with
that in Figure 2A), but eventually reached a cell density
only slightly below that of cultures grown without etha-
nol. In contrast, the cell density of RB50ΔsigE grown in
the presence of 3% ethanol never surpassed an OD600 of
around 0.1, even after 24 hours. Expression of plasmid-
encoded sigE in RB50ΔsigE complemented this
Figure 3 Colonization of the respiratory tract of C57BL/6 mice
by RB50 and RB50ΔsigE. Groups of three 4–6 week-old C57BL/6
mice were inoculated with 5 × 105 CFU of RB50 (filled squares) and
RB50△sigE (open triangles). Groups of three mice were sacrificed at
each time point. The bacterial load in the indicated organ is
expressed as log10 CFU± SE. The dashed line indicates the limit of
detection. The experiment was performed twice with similar results
and a representative dataset is shown.
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to nearly that of RB50 (Figure 2D), indicating that sigE is
required for survival during ethanol stress.
σE homologues have also been found to play a role
during oxidative stress in S. Typhimurium and Burkhol-
deria pseudomallei [29,41]. However, in disk diffusion
assays, SigE was not required for survival in the presence
of hydrogen peroxide or paraquat, two inducers of oxi-
dative stress (data not shown). Either SigE is not
involved in combating oxidative stress in B. bronchisep-
tica, or other oxidative-stress responsive pathways com-
pensate for SigE when it is absent.Growth in the murine respiratory tract is not affected by
the lack of sigE
B. bronchiseptica RB50 colonizes the respiratory tract of
immunocompetent mice, causing an asymptomatic in-
fection that is eventually cleared by the immune system.
To determine whether B. bronchiseptica SigE contributes
to colonization and persistence in the respiratory tract,
groups of C57BL/6 mice were inoculated with RB50 or
RB50ΔsigE. Colonization was measured in the nasal
cavity, trachea, and lung on days 0, 3, 7, 14, 28 and 63
post-inoculation. Both wild-type and sigE-deficient RB50
colonized the nasal cavity at comparable levels, peaking on
day 3 post-inoculation, and stabilizing at about 104-5 CFU
by 2 weeks post-inoculation (Figure 3). Both strains also
showed similar colonization kinetics in the lower respira-
tory tract of C57BL/6 mice, peaking in numbers on days 3
and 7 post-inoculation in the trachea and lungs, respect-
ively, and declining thereafter, with complete clearance in
both organs by day 63 post-inoculation (Figure 3). These
data indicate that B. bronchiseptica SigE is not required
for colonization or persistence in the murine respiratory
tract.
SigE contributes to lethal B. bronchiseptica infection in
mice lacking B cells and T cells, but not in mice lacking
TLR4 or TNF-α
B. bronchiseptica has been observed to cause a range of
disease including bronchitis, lethal pneumonia, and even
systemic infection [11,12]. Mice with defined immune
deficiencies are particularly susceptible to different
forms of disease [44-46], facilitating assessment of the
roles of specific bacterial factors/functions in interac-
tions with different aspects of the host immune
response.
Mice lacking key components of innate immunity,
either TLR4 or TNF-α, were challenged with RB50 or
RB50ΔsigE and signs of severe disease were monitored.
Consistent with published studies, TLR4def and TNF-α−/−
mice inoculated with 105 CFU of RB50 quickly developed
signs of lethal bordetellosis such as ruffled fur, hunched
posture, decreased activity, and difficulty breathing, and
succumbed 2 to 5 days post-inoculation [46,47]. Mice
challenged with RB50ΔsigE also showed similar signs of
disease and time to death (data not shown). In a separate
experiment, TLR4def mice and TNF-α−/− mice infected
with RB50 or RB50ΔsigE that were still alive by day 3
post-inoculation were dissected for bacterial enumeration
in the respiratory as well as systemic organs. Both
wild-type and sigE-deficient RB50 colonized the lungs
of TLR4def mice at 107-8 CFU, which was almost
1000-fold higher than in the lungs of TLR4suf mice.
Moreover, both strains colonized the systemic organs
in TLR4def, but not TLR4suf mice (data not shown).
Both strains also grew to higher numbers in the
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mice and were recovered from systemic organs only
in TNF-α−/− mice (data not shown). These data indi-
cate that SigE is not required for B. bronchiseptica to
cause lethal infection and colonize systemic organs in
mice lacking TLR4 or TNF-α.
B and T cell-deficient Rag1−/− mice succumb to B.
bronchiseptica infection, and death is associated with
systemic spread of the infection [48]. To assess the role
of SigE during infection in hosts deficient in adaptive
immunity, groups of Rag1−/− mice were inoculated with
5 × 105 CFU of RB50 or RB50ΔsigE. Rag1−/− mice inocu-
lated with RB50 showed symptoms of lethal bordetellosis
on day 13 post-inoculation and succumbed between days
14–35 post-inoculation (Figure 4A). However, Rag1−/−
mice inoculated with RB50ΔsigE survived without anyFigure 4 Survival and systemic colonization of Rag1−/− mice
following infection with RB50 and RB50ΔsigE. (A) Groups of Rag1
−/− mice (n = 6) were inoculated with 5 × 105 CFU of RB50 (solid line
with filled squares) or RB50△sigE (dashed line with open triangles)
and monitored for survival. (B) Groups of four Rag1−/− mice were
inoculated with 5 × 105 CFU of RB50 (white bars) or RB50△sigE (light
grey bars) and dissected on day 28 post-inoculation for bacterial
enumeration in the indicated organs. In a separate experiment, Rag1
−/− mice inoculated with RB50△sigE were euthanized for bacterial
numbers in the indicated organs on day 122 post-inoculation (dark
grey bars). The bacterial load is expressed as log10 CFU± SE. Limit of
detection is indicated as the bottom of the y-axis.overt signs of disease and were euthanized on day 122
post-inoculation. The nasal cavity, trachea, lungs, spleen,
liver, and kidneys of these mice were excised to enumer-
ate bacterial loads. Although 105-7 CFU of RB50ΔsigE
were recovered from the respiratory tract, this strain
failed to colonize the spleen or kidney, and only
300 CFU were recovered from the liver (Figure 4B, dark
gray bars). In a separate experiment, RB50 and
RB50ΔsigE-inoculated Rag1−/− mice were sacrificed on
day 28 post-inoculation, when some of the RB50-
challenged mice were still alive. The bacterial loads of
RB50 and RB50ΔsigE in the respiratory tract on day 28
post-inoculation were similar, about 105-7 CFU. At this
time, 104-6 CFU of RB50 were recovered from liver,
spleen, and kidney (Figure 4B, white bars). RB50ΔsigE,
however, failed to colonize the spleen, kidney or liver
(Figure 4B, light gray bars). These results demonstrate
that SigE is required for lethal infection by B. bronchi-
septica in Rag1−/− mice.
The failure of RB50ΔsigE to colonize distal organs of
Rag1−/− mice suggests that this mutant may be defective
in getting into or survival in the bloodstream and/or sys-
temic organs. The bloodstream includes many important
bactericidal factors of the host immune system, includ-
ing complement and phagocytes. We first examined
whether B. bronchiseptica lacking sigE is more suscep-
tible to complement-mediated killing. 500 CFU of RB50,
RB50ΔsigE, or RB50Δwbm, a strain lacking O-antigen,
which is known to be susceptible to complement [48],
were incubated at 37°C for one hour in PBS with 20%
complement-active or complement-inactive serum from
naïve mice. The survival of RB50ΔsigE and RB50 was
not affected by the presence of either serum (data not
shown). In contrast, the RB50Δwbm strain was almost
completely killed by complement-active, but not
complement-inactive serum (0.7% survival in the pres-
ence of complement-active serum compared to 100%
survival in the presence of complement-inactive serum).
The observation that RB50ΔsigE survived in the pres-
ence of serum without B. bronchiseptica-specific anti-
bodies indicates that the defect in causing systemic
infection in mice lacking B and T cells is not due to fail-
ure to survive the antimicrobial components in serum,
including complement.
SigE contributes to cytotoxicity to macrophages
We further tested whether RB50ΔsigE interacts differ-
ently than RB50 with another major bactericidal compo-
nent in the bloodstream, phagocytes. B. bronchiseptica is
cytotoxic to macrophages, and this toxicity has been
attributed to the activities of the type three secretion
system (TTSS) [49]. To test the role of SigE in macro-
phage cytotoxicity, RAW264.7 murine macrophages
were incubated for 4 hours at an MOI of 10 with RB50,
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(WD3). In this experiment, both the RB50 and
RB50ΔsigE strains contained the empty cloning vector
pEV to allow direct comparisons with the complemented
strain, RB50ΔsigE pSigE. Cytotoxicity was determined by
measuring LDH release from the treated macrophages.
WD3 caused little cytotoxicity, similar to treatment with
medium alone. RB50ΔsigE pEV caused approximately
50% less cytotoxicity than wild-type RB50 pEV (Figure 5).
This defect in cytotoxicity was complemented by supply-
ing the sigE gene on the plasmid pSigE (Figure 5), indi-
cating that loss of sigE negatively impacts the ability of
RB50 to kill macrophages.Figure 6 RB50ΔsigE is more efficiently phagocytosed and killed
by PMNs than RB50. (A) GFP-expressing RB50 (white bars) and
RB50ΔsigE (grey bars) were incubated with freshly isolated human
peripheral blood PMNs for 20 min at an MOI of 50. Attachment
levels were measured as mean intensities ± SE of green fluorescenceRB50ΔsigE is more efficiently phagocytosed and killed by
PMNs
To test if RB50ΔsigE is more susceptible to another bac-
tericidal mechanism, phagocytosis by peripheral blood
polymorphonuclear leukocytes (PMNs), RB50 and
RB50ΔsigE were incubated with freshly isolated human
PMNs and attachment to, phagocytosis by, and killing
by these cells were measured. PMNs bound RB50ΔsigE
more efficiently than RB50 (Figure 6A), and significantly
more RB50ΔsigE than RB50 were phagocytosed by
PMNs (Figure 6B). However, the number of viable intra-
cellular RB50ΔsigE was ~50% of the numbers of viable
RB50 (Figure 6C, left panel). When differences inFigure 5 RB50ΔsigE is less cytotoxic to macrophages than
RB50. RAW 264.7 cells were incubated at an MOI of 10 with
medium containing RB50 pEV, RB50△sigE pEV, RB50△sigE pSigE,
TTSS-deficient RB50 strain WD3, or medium alone for 4 hours in the
presence of 1 mM IPTG to induce expression of sigE from the pLac
promoter of pSigE. The average percent cytotoxicity of four wells in
four separate experiments as measured by (LDH release from a well/
LDH release from the positive control well) x100 ± SE is shown. The
differences in percent cytotoxicity between RB50△sigE pEV and
either RB50 pEV or RB50△sigE pSigE are statistically significant (**
indicates P value < 0.01), while the cytotoxicities of RB50 pEV and
RB50△sigE pSigE are not significantly different.
associated with PMNs. (B) Cell surface-bound bacteria were detected
by incubation with RPE-labeled goat F(ab’)2 fragments of anti-mouse
IgG, after incubation with immune serum. Mean phagocytosis
levels ± SE were calculated from the decrease in red fluorescence of
GFP-positive cells incubated for an additional 30 min at 37°C
allowing for internalization (RPE2, 50 min total incubation time)
compared to that of cells incubated for only 20 min (RPE1). Percent
phagocytosis is (1-RPE2/RPE1) × 100%. (C) To determine killing of
bacteria by PMNs, cells incubated with bacteria for 50 min were
treated with antibiotics to kill extracellular bacteria. Viable bacteria
per PMN (left) and percent killing of internalized bacteria (right)
were expressed as mean± SE. AU indicates arbitrary units; * indicates
a P-value of < 0.05.attachment and phagocytosis were taken into consider-
ation, significantly more internalized RB50ΔsigE were
killed compared to RB50 (Figure 6C, right panel). To-
gether, these data indicate that SigE contributes to B.
bronchiseptica resistance to phagocytosis and killing by
PMNs.
Discussion
The BvgAS system of the bordetellae plays a central
role in regulating gene expression during pathogenesis
[50-52]. However, other regulators may be required
during the infectious disease cycle, as Bordetella gen-
omes have a large number of putative sensory systems
Barchinger et al. BMC Microbiology 2012, 12:179 Page 9 of 16
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sensing systems and investigated the alternative sigma
factor, SigE. We found that SigE of B. bronchiseptica
does indeed mediate a protective cell envelope stress re-
sponse and that strains lacking SigE do not establish
lethal infections in mice lacking adaptive immunity.
These data suggest that the role of SigE is to combat
stresses to the envelope imposed by the immune system
within a host and by harsh conditions in the environ-
ment outside a host. This work is the first demonstra-
tion of a cell envelope sensing system in the bordetellae.
The σE system has been explored in the most depth in
enteric pathogens belonging to the Gammaproteobac-
teria [23,25,53]. The bordetellae, members of the
Betaproteobacteria, encounter distinctly different envir-
onments in the respiratory tract and therefore provide
an excellent model to study how the SigE system has
been adapted throughout evolution to serve the needs of
diverse bacterial pathogens.
The entire sigE locus (BB3752-BB3750) is identical at
the amino acid sequence level among the classical bor-
detellae, suggesting a conserved role in the human
pathogens B. pertussis and B. parapertussis. However,
the lifestyles and, therefore, conditions encountered dif-
fer amongst these three species. B. bronchiseptica can
live outside the host and primarily infects mammals,
although it can infect immunocompromised humans
[11,14]. In contrast, B. pertussis and B. parapertussis pri-
marily infect humans and are directly transmitted
between hosts [54,55]. As we learn more about the role
of SigE in the bordetellae, it will be of interest to deter-
mine whether stresses that induce the SigE system and
the SigE regulon members are as highly conserved as
the sigE locus itself among the bordetellae.
Our results define roles for SigE in B. bronchiseptica
that are only partially overlapping with those for σE in
other pathogens. SigE was important for survival of B.
bronchiseptica in the face of both global stresses to the
cell envelope caused by heat shock, exposure to ethanol
and detergent, and specific stresses caused by several
beta-lactam antibiotics (Figure 2). Heat shock, ethanol,
and detergent are classical stressors used in the labora-
tory to mimic conditions that lead to unfolded proteins
and disrupted lipids during infection and in the environ-
ment. In contrast to the B. cenocepacia and S. Typhi-
murium proteins, B. bronchiseptica SigE was not
required for survival during osmotic stress [6,36]. SigE
was also not required for response to oxidative stress or
the antimicrobial peptide polymyxin B, unlike the S.
Typhimurium σE ortholog [6,29]. The variations among
bacteria in their use of σE systems likely reflect both
differences in stresses encountered in environmental
reservoirs and in particular host tissues during infection,
as well as differences in the arrays of additional cellularstress responses possessed by each species. These other
responses can act along with or in place of σE. The pres-
ence of other stress responses may be particularly per-
tinent to B. bronchiseptica. Its genome is predicted to
encode six related ECF sigma factors of unknown func-
tion in addition to SigE [24] that may have complimentary
and redundant functions with SigE. Future studies defining
conditions that activate other ECF sigma factors and their
roles in B. bronchiseptica pathogenesis will provide a more
comprehensive understanding of how B. bronchiseptica
copes with extracytoplasmic stress.
Stress response systems, like the σE system, rapidly in-
duce the expression of specialized sets of genes. These
systems are often tightly regulated and expressed only
when needed, because inappropriate expression of their
regulons can interfere with other important cellular
functions [8,56,57]. We found that SigE was not required
for colonization and persistence of RB50 within the re-
spiratory tract of an immunocompetent host (Figure 3),
the primary niche of B. bronchiseptica. This result sug-
gests that the pathogen does not encounter stresses in
the respiratory tract that require a response by the SigE
system. However, B. bronchiseptica encounters different
challenges during infection in Rag1−/− mice lacking B
and T cells. In these mice, the infection spreads to the
bloodstream, which is under greater immune surveil-
lance and has a different arsenal of antimicrobial factors
to attack invaders than the respiratory tract. The defect
of RB50ΔsigE in lethal infection of Rag1−/− mice, there-
fore, reveals a specific function for SigE in response to
an unknown stress, possibly related to the innate im-
mune response, that the bacteria encounter during infec-
tions that proceed beyond colonization of the
respiratory tract.
The inability of RB50ΔsigE to cause lethal infections in
Rag1−/− mice (Figure 4) could be due to failure to enter
or survive in the bloodstream and/or systemic organs of
these mice. Since the mutation does not affect survival
during incubation with serum in vitro, it is unlikely that
the sigE-deficient strain is more susceptible to comple-
ment or other antimicrobial components in serum. The
defect in infection of Rag1−/− mice may then be related
to altered interactions of the mutant strain with phago-
cytic cells in the bloodstream. RB50ΔsigE is more sus-
ceptible to peripheral blood PMNs than RB50 (Figure 6),
and is also less cytotoxic to macrophages than RB50
(Figure 5). Either or both of these defects could explain
the failure to recover RB50ΔsigE from systemic organs
of mice lacking adaptive immune responses and the
decreased virulence in these mice.
Why does the RB50ΔsigE mutant spread systemically
and cause lethal infection in TLR4def and TNF-α−/− mice,
but not Rag1−/− mice? The lower cytotoxicity of the sigE
mutant and its increased sensitivity to phagocytic killing
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mune functions. This could be because bacterial numbers
within the respiratory tract of TLR4def or TNF-α−/− mice
are nearly an order of magnitude higher than in the lungs
of Rag1−/− mice. As such, the large number of bacteria in
TLR4def or TNF-α−/− mice may overwhelm limiting host
antimicrobial defense mechanisms that can contain the
lower bacterial numbers in the lungs of Rag1−/− mice. Al-
ternatively, although the cytotoxicity of the sigE mutant is
reduced, it may still be sufficient to establish lethal infec-
tions in the absence of TLR4 or TNF-α. Thus TLR4- and
TNF-α-dependent functions, such as efficient phagocyt-
osis and killing, appear to be sufficient to prevent lethalTable 1 Strains and plasmids
Strain name Genotype



















pTrc99a Vector, pBR322 o
pSEB006 sigE in pTrc99a
pSEB015 isolated rpoHP3
pPER76 rpoE in T7 expre
pXQZ001 sigE in T7 expres
pXQZ002 △sigE in TOPO-
pSS1827 helper plasmid c
pSS3962 Bordetella-specif
pXQZ003 △sigE in pSS396
pEV Vector pJS72, ΩS
pSigE sigE in pEV
pCW505 cytoplasmic expinfection by RB50ΔsigE in Rag1−/− mice. Although the
exact role remains to be elucidated, our results clearly in-
dicate that SigE is required for lethal infection of mice
lacking B and T cells.
Although the B. bronchiseptica strain RB50 causes
asymptomatic infections in immunocompetent mice,
other strains of B. bronchiseptica can cause a wide range
of disease severity in other hosts [11-13]. In particular
subsets of immunocompromised humans, such as those
infected with HIV, severe systemic B. bronchiseptica
infections have been observed [14]. These facts, along
with the high degree of sequence conservation for the
sigE locus in B. pertussis and B. parapertussis, highlightsSource, Reference
P3::lacZ △lacX74 [60]
::kan pLysS pPER76 [61]



















promoter in pRLG770, ApR [61]
ssion vector pET15b, KanR [65]
sion vector pET15b, KanR This work
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ompetent for mating, ApR [63]
ic allelic exchange vector, KanR Stibitz, unpublished work
2 This work
pecR cassette replaced with CmR This work
This work
ression of GFP [66]
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vate SigE and how the SigE system responds to them
during infection.Conclusions
In this work, we have demonstrated that the B. bronchi-
septica extracytoplasmic function sigma factor, SigE, is
important for surviving global stresses that affect the
whole cell, such as heat shock and ethanol stress, spe-
cific stresses that target the cell envelope, such as beta-
lactam antibiotics and SDS-EDTA, and in interactions
with the host innate immune system, particularly phago-
cytes. During infection, SigE is not required for
colonization of the respiratory tract of immunocompe-
tent mice. However, it is needed for a specific set of
functions associated with virulence, particularly those
involved in surviving the innate immune response when
the infection progresses in immunocompromised mice.
Although SigE systems are widely conserved, the details
as to which aspects are shared and which have diverged
are complex. As evidence accumulates from studies in
different bacteria, it is becoming apparent that these
sensory modules are important for stress survival, par-
ticularly with respect to the cell envelope. However, the
nature of the stresses that SigE systems combat varies.
During infection, comparisons are even more difficult,
since differences are seen not only amongst SigE systems
from one pathogen to another, but also within different
niches in the host or during the progression of disease
for a single pathogen.Methods
Strains and media
A complete list of strains used in this study can be found
in Table 1. B. bronchiseptica strains are derivatives of the
previously described B. bronchiseptica strain RB50 [58].
B. bronchiseptica was maintained on Bordet-Gengou
(BG) agar (Difco) containing 10% defibrinated sheep
blood (Hema Resources) and 20 μg/ml streptomycin. In
liquid culture, B. bronchiseptica was grown in Stainer-
Scholte broth [59] with aeration. Chloramphenicol
was used at 20 μ/ml and IPTG at 1 mM where
noted. The RB50ΔsigE mutant was constructed as
described below. E. coli strains used to measure SigE
activity are derivatives of MG1655 that carry the σE-
dependent rpoHP3::lacZ reporter (strain SEA001 [34]).
E. coli strain BL21(DE3) pLysS was used to express
constructs for protein purification. E. coli were grown
in LB broth in a gyratory water bath with aeration.
Ampicillin was used at 100 μg/ml, tetracycline at
20 μg/ml, and kanamycin at 15 μg/ml as needed for
experiments with E. coli.Plasmid constructions
All plasmids used in this study are listed in Table 1 and
oligonucleotide sequences are given in Table 2. Plasmid
pSEB006 was constructed to express sigE in E. coli. The
sigE gene was amplified from RB50 genomic DNA with
the primers SigEF and SigER and cloned into the expres-
sion vector pTrc99a under the control of the IPTG-
inducible trc promoter. To facilitate purification of SigE,
the plasmid pXQZ001 was constructed by amplifying
the sigE gene from RB50 genomic DNA using the pri-
mers HisSigEF and HisSigER. The resulting PCR product
was cloned into the T7 expression vector pET-15b
(Novagen), which adds a 6X-His tag to the N-terminus
of recombinant proteins. To express sigE in B. bronchi-
septica, sigE was amplified from RB50 genomic DNA
using primers 72SigEF and 72SigER and ligated into the
XbaI and XhoI sites downstream of the pLac promoter
in pEV to create pSigE. The expression vector pEV was
constructed from the broad host range vector pJS72 by
replacing the spectinomycin resistance gene with the cat
gene encoding chloramphenicol resistance amplified
from pKD3 [67] using primers 72ChlorF and 72ChlorR.
The exchange of drug markers was necessary because
RB50 is naturally resistant to spectinomycin. pEV and
pSigE were moved into RB50 and RB50ΔsigE through
tri-parental mating on BG agar with MgCl2. Transconju-
gants were selected on BG containing 60 μg/ml strepto-
mycin and 20 μg/ml chloramphenicol. Plasmid pCW505
(kindly supplied by Dr. Alison Weiss, Cincinnati, Ohio),
which induces cytoplasmic expression of GFP without
affecting growth or antigen expression, was used to
visualize RB50 and RB50ΔsigE in the phagocytosis assays
described below [68].
Construction of RB50ΔsigE strain
The sigE gene was deleted from RB50 using a Bordetella-
specific allelic exchange procedure to produce strain
SEA5516. Primers used in the construction are listed in
Table 2. A PCR product containing 637 bp proximal to
the 5' end of sigE was amplified from RB50 genomic DNA
using primers SigEKO_LeftF and SigEKO_LeftR. A non-
overlapping PCR product containing 534 bp proximal to
the 3' end of sigE was amplified with primers SigEKO_R-
ightF and SigEKO_RightR. The two fragments were
digested with BamHI and ligated. The resulting construct
was amplified with primers SigEKO_LeftF and SigEKO_R-
ightR, cloned into the TopoTA vector (Invitrogen), and
verified by sequencing to give plasmid pXQ002. In this de-
letion construct, the 528 bp central region of the sigE gene
is deleted leaving 66 bp at the 5' end and 6 bp at the 3'
end of the sigE gene. The deletion construct from pXQ002
was then cloned into the EcoRI site of the allelic exchange
vector pSS3962 (Stibitz S., unpublished data) to generate
pXQ003 and transformed into E. coli strain DH5α. Tri-
Table 2 Primer sequences
Primer name Sequence (5´ - 3´) Source or Reference
SigEF GGCGGAGAATTCAGGAGGAGGCGTCATGAGCGAACGCGATG This work
SigER GGCCTAGGATCCTTACCAGCGACGCTCGGCAT This work
HisSigEF GGCCTGGCATATGAGCGAACGCGATGTCGA This work
HisSigER GGCCTAGGATCCTTACCAGCGACGCTCGGCAT This work
72SigEF GCGCGGTCTAGAAGGAGGAGGCGTCATGAGCGAACGCGATG This work
72SigER GCCCGGCTCGAGTTACCAGCGACGCTCGGCAT This work
72ChlorF GCGGCGGGATCCTGTGTAGGCTGGAGCTGCTTC [67]
72ChlorR GCCGCCGGATCCCATATGAATATCCTCCTTA [67]
SigEKO_LeftF GGGAATTCAAGATCGAGATCGGCCTGTCGAAT This work
SigEKO_LeftR AGGGATCCGAAGGCTTTCTTGTCGCCACGTTGTA This work
SigEKO_RightF AGGGATCCTGGTAAGGAGTGGCAGTCATGCAA This work
SigEKO_RightR GCGAATTCAAAGCAACGGTGTCATCAACGTCC This work
PFamF GGGCGGGAATTCTGCCGTTCGTGGATGTCCAG This work
PFamR GGGCGGAAGCTTGGGCCAACGAACTACTGGGT This work
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RB50, E. coli strain DH5α harboring the pXQ003 vector
(strain XQ003), and DH5α harboring the helper plasmid
pSS1827 (strain SS1827) [69,70] and selection of mutants
were performed as previously described [69]. The deletion
strain was verified by PCR using primers SigEKO_LeftF
and SigEKO_RightR and by Southern blot analysis.
β-galactosidase assays
Overnight cultures were diluted into fresh medium and
grown to an OD600 of 0.1-0.2 at 30°C. Where indicated,
IPTG was added to a final concentration of 1 mM. Sam-
ples were collected 2.5 hours later and β-galactosidase
activity from the σE-dependent reporter was assayed as
previously described [60,71].
Complementation of E. coli ΔrpoE by B. bronchiseptica
sigE
The ability of B. bronchiseptica sigE to suppress the le-
thality caused by deletion of rpoE in E. coli was deter-
mined using a cotransduction assay as described [62].
The ΔrpoE::kan ΔnadB::Tn10 allele from strain
SEA4114 was moved via P1 transdution into strain
SEA5005, which carries sigE on the plasmid pSEB006.
Tet-resistant (tetR) transductants were selected and then
screened for kanamycin resistance (kanR). Although the
nadB and rpoE alleles are tightly linked (>99%), cotrans-
duction resulting in tetR kanR colonies will only occur if
rpoE is no longer essential for viability. In transductions
with E. coli expressing sigE (strain SEA5005) as the re-
cipient strain, 31 out of 32 tetR transductants were also
kanR. In contrast, none of the 39 tetR transductants were
kanR when E. coli carrying the empty cloning vector
(strain SEA008) was the recipient strain.Protein purification
N-terminally His-tagged B. bronchiseptica SigE and E.
coli σE were purified from strain XQZ001 and SEA5036,
respectively, as previously described for E. coli σE [61].
Briefly, cells were grown at 25°C to an OD600 of 0.5, at
which point IPTG was added to induce protein produc-
tion. Following 1.5-3 hours of induction, cells were har-
vested by centrifugation and resuspended in lysis buffer
(20 mM Tris–HCl pH 8.0, 500 mM NaCl, 20 mM imid-
azole, 2.5 mM β-mercaptoethanol, 1 mM PMSF). Resus-
pended cells were then lysed by sonication, and the
lysate cleared by centrifugation. The supernatant con-
taining soluble His-SigE was loaded onto a Ni-NTA col-
umn (Qiagen). Bound proteins were eluted with a
stepwise gradient of 20, 60, 100, and 200 mM imidazole
in column buffer (20 mM Tris–HCl pH 8.0, 500 mM
NaCl, 2.5 mM β–mercaptoethanol). Fractions containing
SigE were pooled and dialyzed into 20 mM Tris–HCl
pH 8.0, 50 mM NaCl, and 2.5 mM β-mercaptoethanol.
In vitro transcription
100 nM E. coli core RNA polymerase (Epicentre) was
incubated with 400 nM His-SigE or His-σE in transcrip-
tion buffer (40 mM Tris–HCl pH 8.0, 10 mM MgCl2,
50 mM NaCl, 1 mM DTT, 0.1 μ/ml BSA) for 10 min at
30°C to form holoenzyme. Multi-round transcription
reactions were initiated by addition of holoenzyme at a
final concentration of 40 nM sigma factor and 10 nM
core RNA polymerase, to prewarmed (30°C) transcrip-
tion mix containing 5.0 nM supercoiled plasmid tem-
plate pSEB015 [61] or 5.0 nM linear Pfam template, 5%
glycerol, 200 mM ATP, 200 mM CTP, 200 mM GTP,
10 mM UTP, and 2.5 mCi [α-32P]UTP in transcription
buffer. After 10 min at 30°C, reactions were stopped by
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EDTA, 0.1% xylene cyanol, and 0.1% bromophenol blue).
Samples were electrophoresed on 6% polyacrylamide
gels containing 7.5 M urea, and transcripts were visua-
lized by phosphorimaging. The linear Pfam template was
generated by amplification of the promoter region of the
gene encoding σ32 in RB50, fam, using the primers
PFamF and PFamR (Table 2). The sequence logo in
Figure 1C was generated using WebLogo version 2.8.2
(http://WebLogo.berkeley.edu, [72]).
Disk diffusion assays
B. bronchiseptica cultures in mid-log phase were diluted
to 6 × 108 CFU/ml and spread on Stainer-Scholte agar
plates to generate a lawn of bacteria. Disks containing
300 IU polymyxin B, 10 μg ampicillin, 100 μg mecilli-
nam, 750 μg sodium dodecyl sulfate (SDS) and 2.9 μg
EDTA, 30 μg aztreonam, 10 μg imipenem, 10 μg mero-
penem, 30 μg chloramphenicol, 15 μg erythromycin,
30 μg kanamycin, 30 μg nalidixic acid, 150 μg rifampicin,
23.75 μg sulfamethoxazole and 1.25 μg trimethoprim,
30 μg tetracycline, 3.0 μg deoxycholate, 3% hydrogen
peroxide, or 2% paraquat were applied to the plates and
the zones of inhibition were measured after overnight
incubation at 37°C.
Temperature and ethanol stress
For temperature stress experiments, mid-log phase cul-
tures of RB50 and RB50ΔsigE were diluted to an OD600
of 0.01 in fresh Stainer-Scholte broth and incubated at
37°C in a gyratory water bath with shaking. At an OD600
of 0.1, cultures were either shifted to 40°C for adaptation
or kept at 37°C. After 90 minutes, all cultures were
shifted to 50°C, and survival was measured by plating
and CFU counts. For ethanol stress experiments, mid-
log-phase cultures of the pertinent strains were subcul-
tured into fresh Stainer-Scholte broth with or without
3% ethanol and incubated at 37°C in a gyratory water
bath with aeration. Bacterial growth was measured by
OD600.
Complement killing assay
Complement killing assays were performed as previously
described [73]. Approximately 500 CFU of RB50,
RB50ΔsigE, and RB50Δwbm from mid-log phase cul-
tures were incubated with 45 μl of diluted serum from
C57BL/6 mice or PBS (final volume for incubation was
50 μl) for 1 hour at 37°C. Bacterial numbers before and
after incubation were determined by plating and CFU
counts. Each strain was assayed in triplicate.
Cytotoxicity assay
Cytotoxicity assays were performed as previously
described [44]. Briefly, bacteria were added to RAW264.7 murine macrophage cells at a multiplicity of infec-
tion (MOI) of 10 and incubated for four hours. Percent
lactate dehydrogenase (LDH) release, a measure of cyto-
toxicity, was determined by using Cytotox96 Kit
(Promega) according to the manufacturer’s protocol.
Phagocytosis and killing by polymorphonuclear
leukocytes
Attachment and phagocytosis of the B. bronchiseptica
strains by peripheral blood polymorphonuclear leukocytes
(PMNs) were evaluated as previously described with a few
modifications [74]. Briefly, GFP-expressing bacteria were
incubated with PMNs at an MOI of 50 for 20 min at 37°C
to allow binding. After extensive washing to remove non-
attached bacteria, an aliquot was maintained on ice to be
used as a bacterial attachment control. The remaining
PMNs were further incubated for 30 min at 37°C to allow
internalization, at which point phagocytosis was stopped
by placing PMNs on ice. Bacteria bound to the cell surface
in both aliquots were detected by incubation with RB50
immune serum for 30 min at 4°C, followed by incubation
with R-phycoerythrin (RPE)–labeled goat F(ab')2 frag-
ments of anti-mouse IgG at 4°C for 30 min. All incuba-
tions were done in the presence of 25% heat-inactivated
human serum to prevent nonspecific binding of anti-
bodies. After washing, ten thousand cells per sample were
analyzed by flow cytometry. Attachment control samples
were also analyzed by fluorescence microscopy using a
DMLB microscope coupled to a DC 100 camera (Leica
Microscopy Systems Ltd.). Green fluorescence intensity
associated with PMNs maintained at 37°C for 20 min has
previously been shown to represent bacterial attachment
[74]. Phagocytosis was calculated from the decrease in
mean red fluorescence intensity of GFP-positive PMNs
after the 30 min incubation allowing for internalization, as
previously described [75]. Percent phagocytosis was calcu-
lated as follows: 100× (1-RPE2/RPE1), where RPE1 is the
mean RPE-fluorescence of the GFP-positive cells after
20 min at 37°C (attachment control) and RPE2 is the
mean RPE-fluorescence of the GFP-positive cells after
50 min (internalized bacteria) at 37°C.
Killing of bacteria by PMNs was assessed as follows:
after phagocytosis of the bacteria, 400 μg/ml polymyxin
B and 350 μg/ml chloramphenicol were added to the
PMNs for 1 hour to kill the remaining extracellular bac-
teria and assess intracellular survival. Serial dilutions of
samples were plated to determine the number of viable
intracellular bacteria per PMN. The relative percent sur-
vival of internalized bacteria was calculated from the
relative phagocytosis index and taking into account the
initial attachment level of each strain, as follows: percent
bacterial killing = [1-N/(A×P)] × 100, where A=number
of bacteria associated with PMN after 20 min at 37°C
(determined by fluorescent microscopy), P = phagocytosis
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cell after incubation with antibiotics. Control experiments
to assess the efficacy of antibiotic bactericidal activity
were performed in parallel. Briefly, samples of 5 × 108 bac-
teria were incubated with antibiotics for 30 min at 37°C
and plated. This resulted in a >99% decrease in CFU.
Animal experiments
C57BL/6J, B6.129 S-Tnftm1Gkl/J (TNF-α−/−), B6 129S7-
Rag1tm1Mom/J (Rag1−/−), C3H/HeOuJ (TLR4suf ) and C3H/
HeJ (TLR4def) mice were obtained from Jackson laborator-
ies (Bar Harbor). All mice were bred in our Bordetella-
free, specific pathogen-free breeding rooms at The Penn-
sylvania State University. For inoculation, mice were
sedated with 5% isoflurane (Abbott laboratory) in oxygen
and 50 μl of PBS containing 105 or 5 × 105 CFU of the
indicated bacteria were pipeted onto the external nares
[76,77]. This method reliably distributes the bacteria
throughout the respiratory tract [76]. Survival curves were
generated by inoculating TLR4def, TNF-α−/− and Rag1−/−
mice with either RB50 or RB50ΔsigE. Mice suffering from
lethal bordetellosis as determined by severe hunched pos-
ture, ruffled fur, extremely labored breathing and apathy
were euthanized to prevent unnecessary suffering [47].
For quantifying bacterial load, mice were euthanized via
CO2 inhalation, and lung, trachea, nasal cavity, spleen,
liver and/or kidneys were excised. Tissues were homoge-
nized in PBS, aliquots were serially diluted, plated, incu-
bated at 37°C for 2 to 3 days, and CFU were determined.
All protocols were reviewed by the university IACUC and
all animals were handled in accordance with institutional
guidelines (IACUC approval number: 31297).
Statistical analysis
The mean +/− standard error (SE) of the geometric mean
was determined when appropriate and expressed as error
bars. Two-tailed, unpaired Student’s T-tests were used to de-
termine statistical significance between groups. All experi-
ments were performed at least twice with similar results.
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